Ambrx garners $10M in new funds
La Jolla, CA-based Ambrx has raised $10 million in new venture funds, adding to the $70 million it has already raised from the likes of 5AM Ventures and Aravis and Versant. Ambrx has been developing a novel protein modification platform. Report
